Agenus
Focus: Agenus is a mid-cap biotechnology company headquartered in Lexington, MA, focused on developing immunotherapies and vaccines for infectious diseases and advanced cancers. The company operates a diversified pipeline of 17 programs spanning Phase 1 through Phase 3 clinical development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Agenus
AI assessmentNot HiringNo open roles listed right now. Follow Agenus to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AGEN2017
Solid TumorClinical Trials (1)
NCT03673020Phase 1a Study to Evaluate Immunogenicity of ASV®
Phase 1Help build intelligence for Agenus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.